.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Prospective clinical investigation of modulated electro hyperthermia as an adjunct to neoadjuvant chemotherapy in breast cancer patients: Enhancing efficacy and objective assessment

Appointment

Date: 27/09/2023

Time: 17:30 – 17:30

Talk time: 0 Min.

Discussion time: 0 Min.

Location / Stream:

Poster 2

Session

Clinical applications & Trial

Topic

Hyperthermia Drug Delivery, Nanoparticles

Authors

Dr. A. Marcell Szasz (Budapest, HU), P. Arkosy (Debrecen, HU), A. Bassam (Gyula, HU), N. Bittner (Budapest, HU), Gy Bodoky (Budapest, HU), K. Boer (Budapest, HU), D Mathe (Budapest, HU), B Gyorffy (Budapest, HU), Z Herold (Budapest, HU), M Herold (Budapest, HU), E Lengyel (Budapest, HU), M Luzbetak (Duesseldorf, DE), Gy Marko-Varga (Lund, SE), Zs Nagy (Budapest, HU), S Spisak (Budapest, HU), Z Szallasi (Boston, MA, US), Gy Szentmartoni (Budapest, HU), M Dank (Budapest, HU)